A 593 amino acid classical non-receptor protein tyrosine phosphatase (PTP), Src-homology-2-containing protein tyrosine phosphatase 2 (SHP2) is encoded by the PTPN11 gene. SHP2 participates in a number of signaling pathways, including PI3K-AKT, JAK-STAT, RAS-MAPK, and PD-1/PD-L1. Additionally, SHP2 controls mitochondrial homeostasis to negatively regulate the activation of the recombinant NLRP3 (NLR family, pyrin domain containing protein 3) inflammasome. SHP2 has been viewed as a very desirable target for treating human diseases, particularly cancer.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V69757 | SHP2-IN-17 | 2941498-93-5 | SHP2-IN-17 (compound 192) is a SHP2 inhibitor (antagonist) with IC50 of 2 nM. |
![]() |
V69759 | SHP2-IN-18 | 2941498-87-7 | SHP2-IN-18 (compound 183) is a SHP2 inhibitor (antagonist) with IC50 of 3 nM. |
![]() |
V69749 | SHP2-IN-19 | 2941498-84-4 | SHP2-IN-19 (compound 183) is a SHP2 inhibitor (antagonist) with IC50 of 3 nM. |
![]() |
V69755 | SHP2-IN-20 | 2941498-94-6 | SHP2-IN-20 (compound 193) is a SHP2 inhibitor (antagonist) with IC50 of 3 nM. |
![]() |
V69750 | SHP2-IN-21 | 2941499-08-5 | SHP2-IN-21 (compound 208) is a SHP2 inhibitor (antagonist) with IC50 of 3 nM. |
![]() |
V69756 | SHP2-IN-22 | 2802453-88-7 | SHP2-IN-22 is an allosteric inhibitor of SHP2 with IC50 of 17.7 nM. |
![]() |
V84645 | SHP2-IN-24 | ||
![]() |
V88063 | SHP2-IN-27 | 2376012-00-7 | SHP2-IN-27 (compound 28) is an allosteric inhibitor of tyrosine phosphatase SH2. |
![]() |
V88065 | SHP2-IN-28 | SHP2-IN-28 (Compound 7188-0011) is an inhibitor of Src homology 2-containing protein tyrosine phosphatase 2 (SHP2) (IC50=54.31 μM). | |
![]() |
V99649 | SHP2-IN-31 | 2411321-35-0 | SHP2-IN-31 is a SHP2 inhibitor with IC50 of 13 nM (wild-type SHP2), >10000 nM (SHP1), >10000 nM (SHP2 E76K). |
![]() |
V97081 | SHP2-IN-32 | 3043685-80-6 | SHP2-IN-32 (Compound C6) is an orally available allosteric SHP2 inhibitor with IC50 of 0.13 nM. |
![]() |
V104461 | SHP2-IN-33 | 2894017-46-8 | SHP2-IN-33 (Compound D13) is an allosteric inhibitor of SHP2 with IC50 of 1.2 μM for SHP2. |
![]() |
V104863 | SHP2-IN-34 | 2924065-12-1 | SHP2-IN-34 (Compound A8) is a phenylurea SHP2 inhibitor with anticancer activity. |
![]() |
V69744 | SHP2-IN-5 | 54755-93-0 | SHP2-IN-5 (compound 1) is a SHP2 inhibitor (IC50= 97 nM). |
![]() |
V51177 | SHP2-IN-6 | 2169223-48-5 | SHP2 inhibitor |
![]() |
V51178 | SHP2-IN-6 HCl | 2169223-49-6 | SHP2 inhibitor |
![]() |
V69752 | SHP844 | 2222280-82-0 | SHP844 is a SHP2 inhibitor (antagonist) with IC50 of 18.9 µM. |
![]() |
V84772 | Suchilactone (Jatrophan) | 50816-74-5 | |
![]() |
V88062 | TK-642 | 2765183-10-4 | TK-642 is a highly active, selective, orally active allosteric SHP2 inhibitor based on pyrazolopyrazine (IC50=2.7 nmol/L). |
![]() |
V80061 | YF704 | 2956716-97-3 | YF704 (compound 4w) is a selective allosteric inhibitor of SHP2 (IC50=0.25 μM). |